Fact Sheet for Healthcare Providers: Interpreting ADVIA Centaur ® Zika Test Results

U.S. Food and Drug Administration. 09/18/2017 This four-page document provides information about the Food and Drug Administration (FDA) ' s issuing of an Emergency Use Authorization (EUA) to authorize the use of the Siemens Healthcare Diagnostics Inc. (Siemens) ADVIA Centaur ® Zika test. This assay provides in vitro qualitative detection of IgM antibodies to the Zika virus. It is intended for use in human serum and plasma specimens of individuals meeting Centers for Disease Control and Prevention (CDC) Zika clinical and/or epidemiological criteria for testing. (PDF)

Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - October 5, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news